Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prevention of Sporadic Colorectal Adenomas With Celecoxib

Trial Profile

Prevention of Sporadic Colorectal Adenomas With Celecoxib

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jan 2017

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Colorectal cancer; Polyps; Sporadic adenomas
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms APC
  • Most Recent Events

    • 21 Jan 2017 Results of a biomarker analysis presented at the 2017 Gastrointestinal Cancers Symposium.
    • 22 Apr 2013 Endpoints updated (ex VANS).
    • 11 Apr 2013 Planned number of patients changed from 1000 to 1170 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top